F&O Call: Nandish Shah recommends to long Glenmark Pharma futures
The derivative analyst from HDFC Securities expects Glenmark Pharma January futues to test Rs 450 on the upside.
The derivative analyst from HDFC Securities expects Glenmark Pharma January futues to test Rs 450 on the upside.